California officials jumped at the chance to cover millions more low-income people by expanding its Medicaid program. Now, health policymakers and advocates fear the Trump administration and a Republican-ruled Congress will roll back the state’s progress.
Any proposals to rein in prescription drug costs will likely come from states, rather than national lawmakers, experts say.
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
The insurer is on the hook for $25 million in refunds to about 240,000 enrollees with employer coverage.
A Cal/OSHA rule approved Thursday offers new protections to workers, some of whom have been attacked and injured, even killed, on the job.
Advocates hope better data will help ethnic communities.
Medicaid enrollment and total spending are projected to rise more slowly for 2017, but California and other states’ tabs will grow faster as the federal government begins to taper funding for Obamacare expansions, the Kaiser Family Foundation reports.
California might not need one, UCLA health policy expert Gerald Kominski said in an interview — but he added that it could provide a backstop against potential future retrenchment by private sector health plans in the state’s ACA insurance exchange.
The state tax would boost the Medi-Cal budget by millions, but it’s unclear how the money will be distributed. And that’s by design.
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans’ sympathetic and trusted image to win over voters.